EUVIMEDOpdag EUVIMED
MetaanalyseSystematische ÜbersichtOpen access

The Impact of Telemedicine Interventions on Maternal and Fetal Outcomes in Women With Gestational Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Auswirkungen telemedizinischer Interventionen auf mütterliche und fetale Outcomes bei Frauen mit Gestationsdiabetes: systematische Übersichtsarbeit und Metaanalyse randomisierter kontrollierter Studien

Hongyue He, Juan Deng, Jingxian Liu, Xiaohong Xu, Jiao Chen, Lixin Liu, Haoyue Zhang, Fang Wang

Journal of Medical Internet Research · 2026-10-23 · 28 · e103569-e103569

DOI: 10.2196/103569 ↗

Auf einen Blick

23 RCTs mit 3055 Frauen mit Gestationsdiabetes: Telemedizin war mit günstigeren glykemischen Werten und einigen perinatalen Outcomes verbunden, die Evidenz war jedoch sehr unsicher.

Fragestellung

Welche Wirkung haben telemedizinische Interventionen im Vergleich zur Standardversorgung auf glykämische Kontrolle und schwangerschaftsbezogene Outcomes bei Frauen mit Gestationsdiabetes?

Methode

Systematische Übersichtsarbeit und Metaanalyse von RCTs; Suche in PubMed, Embase, Cochrane Library, Web of Science und Scopus bis 16. August 2026; Bewertung mit RoB 2 und GRADE.

Ergebnisse

23 RCTs mit 3055 Frauen. Fasting glucose: MD −0,26 (95 %-KI −0,42 bis −0,09; 95 %-PI −0,93 bis 0,42); 2-hour postprandial glucose: MD −0,50 (95 %-KI −0,87 bis −0,14; 95 %-PI −1,84 bis 0,84); gestational weight gain: MD −0,78 (95 %-KI −1,40 bis −0,17; 95 %-PI −2,83 bis 1,26).

Einschränkungen

Sehr hohe, unerklärte Heterogenität bei fasting glucose, 2-hour postprandial glucose und gestational weight gain; 95 %-PIs kreuzten die Nulllinie; Evidenz sehr niedrig bis niedrig.

Schlussfolgerung der Autor:innen

Telemedizin kann ausgewählte glykämische und perinatale Outcomes verbessern, sollte Standardvorsorge aber nach derzeitiger Evidenz nicht vollständig ersetzen.

Kernaussagen

  • Fasting glucose, 2-hour postprandial glucose und Gewichtszunahme waren günstiger
  • Auch Kaiserschnitt, Makrosomie und neonatale Hypoglykämie waren seltener
  • Evidenzgrad insgesamt sehr niedrig bis niedrig

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Metaanalyse in Journal of Medical Internet Research, published online on 2026-10-23. Written by Hongyue He and 7 co-authors. Institution: School of Nursing, Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Chengdu, Sichuan, China. Major MEDLINE topics: Diabetes, Gestational, Pregnancy Outcome, Telemedicine. 59 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Gestational diabetes mellitus (GDM) has a rising global prevalence and brings short-term and long-term adverse risks for mothers and fetuses. Conventional in-person GDM care is limited by time and geographic barriers, often resulting in suboptimal compliance and delayed individualized interventions. Telemedicine is increasingly applied in GDM management; however, randomized controlled trial (RCT) evidence remains inconsistent.

Objective

The study aims to pool data from RCTs to quantify the effects of telemedicine on glycemic control and pregnancy-related outcomes in women with GDM and to inform optimized clinical management.

Methods

We searched PubMed, Embase, Cochrane Library, Web of Science, and Scopus up to August 16, 2026. Two reviewers independently performed study screening and data extraction. Risk of bias was assessed using RoB 2. Meta-analyses were conducted in Stata 18.0. For heterogeneous outcomes, 95% prediction intervals (PIs) were calculated to estimate effect ranges for future studies. Heterogeneity was explored via leave-one-out sensitivity, meta-regression, and subgroup analyses. The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework rated evidence certainty. Publication bias was evaluated for outcomes reported in ≥10 studies.

Results

Twenty-three RCTs (3055 women with GDM) were included. Pooled estimates suggested that telemedicine may reduce fasting glucose (mean difference [MD] −0.26, 95% CI −0.42 to −0.09, 95% PI −0.93 to 0.42; P =.002), 2-hour postprandial glucose (MD −0.50, 95% CI −0.87 to −0.14, 95% PI −1.84 to 0.84; P =.007), and gestational weight gain (MD −0.78, 95% CI −1.40 to −0.17, 95% PI −2.83 to 1.26; P =.01). Telemedicine was also associated with lower risks of cesarean section, emergency cesarean section, macrosomia, neonatal hypoglycemia, and neonatal respiratory distress. No significant differences were found for hemoglobin A 1c , preterm birth, or neonatal intensive care unit admission. Notably, fasting glucose, 2-hour postprandial glucose, and gestational weight gain exhibited very high unexplained heterogeneity ( I ²>90%), with their 95% PIs crossing the null value despite statistically significant pooled effects. The GRADE certainty of evidence was very low to low across all assessed outcomes.

Conclusions

Telemedicine may improve selected glycemic and perinatal outcomes for women with GDM and may serve as a promising supplementary option for prenatal care, particularly in resource-limited settings where routine in-person follow-up is difficult to implement. Nevertheless, the apparent benefits for glycemic control and gestational weight gain remain tentative due to extreme, unexplained between-study heterogeneity and 95% PIs crossing the null. Based on current evidence, telemedicine should not completely replace standard antenatal care. Future well-designed, large-sample RCTs are warranted; such trials should adopt standardized definitions for telemedicine interventions, fully report intervention components, and conduct long-term follow-up to verify sustained maternal and neonatal clinical benefits.

Subjects

MeSH terms (MEDLINE)

Diabetes, GestationalPregnancy OutcomeTelemedicineFemaleHumansPregnancyRandomized Controlled Trials as Topic

Author keywords

gestational diabetes mellitusmaternal and fetal outcomesmeta-analysissystematic reviewtelemedicine

Authors and institutions

  • School of Nursing, Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Chengdu, Sichuan, China.
  • Department of Orthopedics, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39, Shierqiao Road, Chengdu, Sichaun, China.
  • School of Medicine, University of Electronic Science and Technology of China, No. 4, Section 2, Jianshe North Road, Chengdu, Sichuan, China.
  • Dean's Office, Guang'an Hospital of Traditional Chinese Medicine, No. 1 Cuiping Road, Guang'an, Sichuan, 638099, China, 86 15520799476.

Cite

APA

He, H., Deng, J., Liu, J., Xu, X., Chen, J., Liu, L., Zhang, H., & Wang, F. (2026). The Impact of Telemedicine Interventions on Maternal and Fetal Outcomes in Women With Gestational Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Medical Internet Research, 28, e103569-e103569. https://doi.org/10.2196/103569

Vancouver

He H, Deng J, Liu J, Xu X, Chen J, Liu L, et al. The Impact of Telemedicine Interventions on Maternal and Fetal Outcomes in Women With Gestational Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Medical Internet Research. 2026;28:e103569-e103569. doi:10.2196/103569

BibTeX
@article{He2026,
  author = {He, Hongyue and Deng, Juan and Liu, Jingxian and Xu, Xiaohong and Chen, Jiao and Liu, Lixin and Zhang, Haoyue and Wang, Fang},
  title = {The Impact of Telemedicine Interventions on Maternal and Fetal Outcomes in Women With Gestational Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e103569--e103569},
  doi = {10.2196/103569}
}
Start for free →